Published in Women's Health Weekly, October 6th, 2005
"The aim of this prospective study was to evaluate the efficacy of gonadotrophin-releasing hormone antagonist (GnRH) in comparison with the standard long protocol in poor-responder patients. Sixty patients with poor ovarian response in previous treatment cycles were randomized into two groups: group A (n=30) was stimulated with a standard long protocol, and group B (n=30) received GnRH antagonist," scientists writing in the journal Reproductive Biomedicine Online report.
"Vaginal ultrasound was performed to evaluate ovarian response....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly